# RECEPTOR_DESIGN — Project Gaps

Phases 1–5 are largely complete. Quantitative structural comparisons have been initiated.

---

## Completed Since Last Review

- **RMSD & Binding Pocket Documentation:** Quantitative comparison between WT (`5i6z_A`) and S348T mutants completed. RMSD values and interaction counts (H-bonds, contacts) are documented in `output/analysis_report.md` and `output/analysis_report.html`.
- **Log Summarization:** ChimeraX session logs have been summarized and filtered in `output/1.md` and `output/1_filtered.md`.
- **Initial Automation:** `scripts/sert_analysis.cxc` provides a baseline for reproducible ChimeraX sessions.

---

## Results / Outputs (Remaining)

- **Exported Figures:** No high-resolution PNGs/images of the structural overlay or binding pocket. (Current reports use text-based summaries).
- **`Annotations.txt` is blank:** Still needs qualitative observations and mutation rationale beyond the automated counts.

---

## Reproducibility (Remaining)

- **`requirements.txt` is minimal:** Only contains `rdkit`. Needs verification of other dependencies (e.g., `biopython`, `pandas`, `numpy`) used in notebooks.
- **Hardcoded Paths:** `Escitalopram_PythonPDB.ipynb` still likely points to local `/Downloads/` paths.
- **Notebooks to Scripts:** RDKit and Reverse Translation logic remains in `.ipynb` format; standalone `.py` scripts are missing for batch processing.

---

## Data Integrity

- **`5I6Z_edited.fasta` Verification:** Still appears identical to WT. Need to confirm if the S348T mutation was intended to be reflected in the sequence file or if it's purely a structural (PDB-level) edit.

---

## Analysis Gaps

- **Molecular Docking:** No formal docking simulation (AutoDock Vina/Glide) has been run to score the binding affinity of Escitalopram across the different mutant models.
- **MD Simulations:** Long-term goal for stability analysis not yet addressed.

---

## Minimum to Call It Complete

1. Export high-quality ChimeraX figures and integrate into `analysis_report.html`.
2. Populate `Annotations.txt` with specific structural insights (e.g., "Threonine 348 introduces a new potential H-bond donor...").
3. Fix notebook paths and expand `requirements.txt`.
4. Perform basic docking run to complement the static RMSD analysis.
